March 16, 2017 — The featured clinical investigation article of the March 2017 issue of the ...
Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.
News | Radiopharmaceuticals and Tracers | March 16, 2017
News | Prostate Cancer | March 09, 2017
March 9, 2017 — Michigan Medicine and the University of Michigan have launched the nation’s first prostate cancer...
This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)
News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...
News | Radiation Therapy | February 17, 2017
February 17, 2017 — Accuray Inc. recently announced data from a prospective, Phase II, 17-center study which showed...
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017
February 13, 2017 — aycan recently introduced ayDCE software powered by aycan workstation. The new software helps...
News | Radiopharmaceuticals and Tracers | February 07, 2017
February 7, 2017 — Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of...
News | Prostate Cancer | February 03, 2017
February 3, 2017 — Adding hormonal therapy to radiation treatment can significantly improve the average long-term...
Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.
News | Prostate Cancer | February 02, 2017
February 2, 2017 — In the featured article from the February 2017 issue of the Journal of Nuclear Medicine,...
News | Prostate Cancer | January 18, 2017
January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of...
News | Patient Positioning Radiation Therapy | January 16, 2017
January 16, 2017 — Augmenix Inc. announced that the International Journal of Radiation Oncology Biology and Physics...
News | Radiopharmaceuticals and Tracers | January 06, 2017
January 6, 2017 — New research demonstrates that a novel...
News | Focused Ultrasound Therapy | December 22, 2016
Insightec Ltd. announced that the Exablate Prostate system received CE Mark for treating locally-confined prostate...
News | Prostate Cancer | December 22, 2016
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics...
News | Prostate Cancer | December 14, 2016
December 14, 2016 — Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on...
News | Prostate Cancer | December 09, 2016
Exact Imaging, a leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance...
Uptake of 89Zr-11B6 in the prostate of a transgenic mouse with prostate cancer. Image courtesy of Daniel Thorek
News | Prostate Cancer | November 30, 2016
November 30, 2016 — An international group of researchers report success in mice of a method of using...
Technology | Prostate Cancer | November 10, 2016
November 10, 2016 — Augmenix Inc. announced that the American Medical Association (AMA) has granted a Category I,...
News | Prostate Cancer | November 02, 2016
November 2, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests a lot more American men...
News | Prostate Cancer | October 27, 2016
October 27, 2016 — Augmenix Inc. announced the three-year results from the SpaceOAR System...
News | Brachytherapy Systems | October 25, 2016
October 25, 2016 — For men with intermediate-risk...
